Cancers,
Journal Year:
2022,
Volume and Issue:
14(18), P. 4457 - 4457
Published: Sept. 14, 2022
(1)
Background:
Gliomas
are
the
most
common
primary
brain
neoplasms
accounting
for
roughly
40−50%
of
all
malignant
central
nervous
system
tumors.
We
aim
to
develop
a
deep
learning-based
framework
automated
segmentation
and
prediction
biomarkers
prognosis
in
patients
with
gliomas.
(2)
Methods:
In
this
retrospective
two
center
study,
were
included
if
they
had
diagnosis
glioma
known
surgical
histopathology
preoperative
MRI
FLAIR
sequence.
The
entire
tumor
volume
including
hyperintense
infiltrative
component
necrotic
cystic
components
was
segmented.
Deep
U-Net
developed
based
on
symmetric
architecture
from
512
×
segmented
maps
as
ground
truth
mask.
(3)
Results:
final
cohort
consisted
208
mean
±
standard
deviation
age
(years)
56
15
M/F
130/78.
DSC
generated
mask
0.93.
Prediction
IDH-1
MGMT
status
performance
AUC
0.88
0.62,
respectively.
Survival
<18
months
demonstrated
0.75.
(4)
Conclusions:
Our
can
detect
segment
gliomas
excellent
biomarker
survival.
Sensors,
Journal Year:
2023,
Volume and Issue:
23(2), P. 634 - 634
Published: Jan. 5, 2023
Artificial
intelligence
(AI)
with
deep
learning
models
has
been
widely
applied
in
numerous
domains,
including
medical
imaging
and
healthcare
tasks.
In
the
field,
any
judgment
or
decision
is
fraught
risk.
A
doctor
will
carefully
judge
whether
a
patient
sick
before
forming
reasonable
explanation
based
on
patient's
symptoms
and/or
an
examination.
Therefore,
to
be
viable
accepted
tool,
AI
needs
mimic
human
interpretation
skills.
Specifically,
explainable
(XAI)
aims
explain
information
behind
black-box
model
of
that
reveals
how
decisions
are
made.
This
paper
provides
survey
most
recent
XAI
techniques
used
related
applications.
We
summarize
categorize
types,
highlight
algorithms
increase
interpretability
topics.
addition,
we
focus
challenging
problems
applications
provide
guidelines
develop
better
interpretations
using
concepts
image
text
analysis.
Furthermore,
this
future
directions
guide
developers
researchers
for
prospective
investigations
clinical
topics,
particularly
imaging.
Frontiers in Oncology,
Journal Year:
2022,
Volume and Issue:
12
Published: Feb. 17, 2022
The
high-throughput
extraction
of
quantitative
imaging
features
from
medical
images
for
the
purpose
radiomic
analysis,
i.e.,
radiomics
in
a
broad
sense,
is
rapidly
developing
and
emerging
research
field
that
has
been
attracting
increasing
interest,
particularly
multimodality
multi-omics
studies.
In
this
context,
analysis
multidimensional
data
plays
an
essential
role
assessing
spatio-temporal
characteristics
different
tissues
organs
their
microenvironment.
Herein,
recent
developments
method,
including
manually
defined
features,
acquisition
preprocessing,
lesion
segmentation,
feature
extraction,
selection
dimension
reduction,
statistical
model
construction,
are
reviewed.
addition,
deep
learning-based
techniques
automatic
segmentation
being
analyzed
to
address
limitations
such
as
rigorous
workflow,
manual/semi-automatic
annotation,
inadequate
criteria,
multicenter
validation.
Furthermore,
summary
current
state-of-the-art
applications
technology
disease
diagnosis,
treatment
response,
prognosis
prediction
perspective
radiology
images,
histopathology
three-dimensional
dose
distribution
data,
oncology,
presented.
potential
value
diagnostic
therapeutic
strategies
also
further
analyzed,
first
time,
advances
challenges
associated
with
dosiomics
radiotherapy
summarized,
highlighting
latest
progress
radiomics.
Finally,
robust
framework
presented
recommendations
future
development
discussed,
but
not
limited
factors
affect
stability
(medical
big
multitype
expert
knowledge
medical),
data-driven
processes
(reproducibility
interpretability
studies,
alternatives
various
institutions,
prospective
researches
clinical
trials),
thoughts
on
directions
(the
capability
achieve
open
platform
analysis).
IEEE Transactions on Medical Imaging,
Journal Year:
2022,
Volume and Issue:
41(6), P. 1520 - 1532
Published: Jan. 26, 2022
The
accurate
prediction
of
isocitrate
dehydrogenase
(IDH)
mutation
and
glioma
segmentation
are
important
tasks
for
computer-aided
diagnosis
using
preoperative
multimodal
magnetic
resonance
imaging
(MRI).
two
ongoing
challenges
due
to
the
significant
inter-tumor
intra-tumor
heterogeneity.
existing
methods
address
them
mostly
based
on
single-task
approaches
without
considering
correlation
between
tasks.
In
addition,
acquisition
IDH
genetic
labels
is
expensive
costly,
resulting
in
a
limited
number
data
modeling.
To
comprehensively
these
problems,
we
propose
fully
automated
MRI-based
multi-task
learning
framework
simultaneous
genotyping.
Specifically,
task
heterogeneity
tackled
with
hybrid
CNN-Transformer
encoder
that
consists
convolutional
neural
network
transformer
extract
shared
spatial
global
information
learned
from
decoder
multi-scale
classifier
Then,
loss
designed
balance
by
combining
classification
functions
uncertain
weights.
Finally,
an
uncertainty-aware
pseudo-label
selection
proposed
generate
pseudo-labels
larger
unlabeled
improving
accuracy
genotyping
semi-supervised
learning.
We
evaluate
our
method
multi-institutional
public
dataset.
Experimental
results
show
achieves
promising
performance
outperforms
counterparts
other
state-of-the-art
methods.
With
introduction
data,
further
improves
source
codes
publicly
available
at
https://github.com/miacsu/MTTU-Net.git
.
Cancers,
Journal Year:
2022,
Volume and Issue:
14(12), P. 2860 - 2860
Published: June 9, 2022
Radiogenomics,
a
combination
of
“Radiomics”
and
“Genomics,”
using
Artificial
Intelligence
(AI)
has
recently
emerged
as
the
state-of-the-art
science
in
precision
medicine,
especially
oncology
care.
Radiogenomics
syndicates
large-scale
quantifiable
data
extracted
from
radiological
medical
images
enveloped
with
personalized
genomic
phenotypes.
It
fabricates
prediction
model
through
various
AI
methods
to
stratify
risk
patients,
monitor
therapeutic
approaches,
assess
clinical
outcomes.
shown
tremendous
achievements
prognosis,
treatment
planning,
survival
prediction,
heterogeneity
analysis,
reoccurrence,
progression-free
for
human
cancer
study.
Although
immense
performance
care
aspects,
it
several
challenges
limitations.
The
proposed
review
provides
an
overview
radiogenomics
viewpoints
on
role
terms
its
promises
computational
well
oncological
aspects
offers
opportunities
era
medicine.
also
presents
recommendations
diminish
these
obstacles.
Current Oncology,
Journal Year:
2023,
Volume and Issue:
30(3), P. 2673 - 2701
Published: Feb. 22, 2023
The
application
of
artificial
intelligence
(AI)
is
accelerating
the
paradigm
shift
towards
patient-tailored
brain
tumor
management,
achieving
optimal
onco-functional
balance
for
each
individual.
AI-based
models
can
positively
impact
different
stages
diagnostic
and
therapeutic
process.
Although
histological
investigation
will
remain
difficult
to
replace,
in
near
future
radiomic
approach
allow
a
complementary,
repeatable
non-invasive
characterization
lesion,
assisting
oncologists
neurosurgeons
selecting
best
option
correct
molecular
target
chemotherapy.
AI-driven
tools
are
already
playing
an
important
role
surgical
planning,
delimiting
extent
lesion
(segmentation)
its
relationships
with
structures,
thus
allowing
precision
surgery
as
radical
reasonably
acceptable
preserve
quality
life.
Finally,
AI-assisted
prediction
complications,
recurrences
response,
suggesting
most
appropriate
follow-up.
Looking
future,
AI-powered
promise
integrate
biochemical
clinical
data
stratify
risk
direct
patients
personalized
screening
protocols.
Frontiers in Artificial Intelligence,
Journal Year:
2024,
Volume and Issue:
7
Published: July 25, 2024
Cancer
research
encompasses
data
across
various
scales,
modalities,
and
resolutions,
from
screening
diagnostic
imaging
to
digitized
histopathology
slides
types
of
molecular
clinical
records.
The
integration
these
diverse
for
personalized
cancer
care
predictive
modeling
holds
the
promise
enhancing
accuracy
reliability
screening,
diagnosis,
treatment.
Traditional
analytical
methods,
which
often
focus
on
isolated
or
unimodal
information,
fall
short
capturing
complex
heterogeneous
nature
data.
advent
deep
neural
networks
has
spurred
development
sophisticated
multimodal
fusion
techniques
capable
extracting
synthesizing
information
disparate
sources.
Among
these,
Graph
Neural
Networks
(GNNs)
Transformers
have
emerged
as
powerful
tools
learning,
demonstrating
significant
success.
This
review
presents
foundational
principles
learning
including
oncology
taxonomy
strategies.
We
delve
into
recent
advancements
in
GNNs
oncology,
spotlighting
key
studies
their
pivotal
findings.
discuss
unique
challenges
such
heterogeneity
complexities,
alongside
opportunities
it
a
more
nuanced
comprehensive
understanding
cancer.
Finally,
we
present
some
latest
pan-cancer
By
surveying
landscape
our
goal
is
underline
transformative
potential
Transformers.
Through
technological
methodological
innovations
presented
this
review,
aim
chart
course
future
promising
field.
may
be
first
that
highlights
current
state
applications
using
transformers,
sources,
sets
stage
evolution,
encouraging
further
exploration
care.
Brain Sciences,
Journal Year:
2024,
Volume and Issue:
14(3), P. 296 - 296
Published: March 20, 2024
In
this
paper,
we
discuss
how
the
clustering
analysis
technique
can
be
applied
to
analyze
functional
magnetic
resonance
imaging
(fMRI)
time-series
data
in
context
of
glioblastoma
(GBM),
a
highly
heterogeneous
brain
tumor.
The
precise
characterization
GBM
is
challenging
and
requires
advanced
analytical
approaches.
We
have
synthesized
existing
literature
provide
an
overview
algorithms
help
identify
unique
patterns
within
dynamics
GBM.
Our
review
shows
that
fMRI
time
series
has
great
potential
for
improving
differentiation
between
various
subtypes
GBM,
which
pivotal
developing
personalized
therapeutic
strategies.
Moreover,
method
proves
effective
capturing
temporal
changes
occurring
enhancing
monitoring
disease
progression
response
treatment.
By
thoroughly
examining
consolidating
current
research,
paper
contributes
understanding
techniques
refine
This
article
emphasizes
importance
incorporating
cutting-edge
into
neuroimaging
neuro-oncology
research.
providing
detailed
perspective,
approach
may
guide
future
investigations
boost
development
tailored
strategies
Cancer Biology and Medicine,
Journal Year:
2022,
Volume and Issue:
19(10), P. 1460 - 1476
Published: Nov. 1, 2022
Objective:
We
aimed
to
summarize
the
clinicopathological
characteristics
and
prognostic
features
of
various
molecular
subtypes
diffuse
gliomas
(DGs)
in
Chinese
population.
Methods:
In
total,
1,418
patients
diagnosed
with
DG
between
2011
2017
were
classified
into
5
according
2016
WHO
classification
central
nervous
system
tumors.
The
IDH
mutation
status
was
determined
by
immunohistochemistry
and/or
DNA
sequencing,
1p/19q
codeletion
detected
fluorescence
situ
hybridization.
median
clinical
follow-up
time
1,076
days.
T-tests
chi-square
tests
used
compare
characteristics.
Kaplan-Meier
Cox
regression
methods
evaluate
factors.
Results:
Our
cohort
included
15.5%
lower-grade
gliomas,
IDH-mutant
1p/19q-codeleted
(LGG-IDHm-1p/19q);
18.1%
(LGG-IDHm);
13.1%
IDH-wildtype
(LGG-IDHwt);
36.1%
glioblastoma,
(GBM-IDHwt);
17.2%
(GBM-IDHm).
Approximately
63.3%
enrolled
primary
overall
survival
times
for
LGG-IDHm,
LGG-IDHwt,
GBM-IDHwt,
GBM-IDHm
75.97,
34.47,
11.57,
15.17
months,
respectively.
5-year
rate
LGG-IDHm-1p/19q
76.54%.
observed
a
significant
association
high
resection
favorable
outcomes
across
all
also
role
chemotherapy
prolonging
GBM-IDHwt
GBM-IDHm,
post-relapse
2
recurrent
GBM
subtypes.
Conclusions:
By
controlling
subtypes,
we
found
that
factors
associated
DG.
Cancers,
Journal Year:
2022,
Volume and Issue:
14(16), P. 4052 - 4052
Published: Aug. 22, 2022
Brain
tumor
characterization
(BTC)
is
the
process
of
knowing
underlying
cause
brain
tumors
and
their
characteristics
through
various
approaches
such
as
segmentation,
classification,
detection,
risk
analysis.
The
substantial
includes
identification
molecular
signature
useful
genomes
whose
alteration
causes
tumor.
radiomics
approach
uses
radiological
image
for
disease
by
extracting
quantitative
features
in
artificial
intelligence
(AI)
environment.
However,
when
considering
a
higher
level
genetic
information
mutation
status,
combined
study
“radiomics
genomics”
has
been
considered
under
umbrella
“radiogenomics”.
Furthermore,
AI
radiogenomics’
environment
offers
benefits/advantages
finalized
outcome
personalized
treatment
individualized
medicine.
proposed
summarizes
tumor’s
prospect
an
emerging
field
research,
i.e.,
radiogenomics
environment,
with
help
statistical
observation
risk-of-bias
(RoB)
PRISMA
search
was
used
to
find
121
relevant
studies
review
using
IEEE,
Google
Scholar,
PubMed,
MDPI,
Scopus.
Our
findings
indicate
that
both
have
successfully
applied
aggressively
several
oncology
applications
numerous
advantages.
paradigm,
conventional
deep
made
impact
on
favorable
outcomes
BTC.
analysis
better
understanding
architectures
stronger
benefits
providing
bias
involved
them.
Life,
Journal Year:
2022,
Volume and Issue:
13(1), P. 24 - 24
Published: Dec. 22, 2022
Brain
tumors
are
a
widespread
and
serious
neurological
phenomenon
that
can
be
life-
threatening.
The
computing
field
has
allowed
for
the
development
of
artificial
intelligence
(AI),
which
mimic
neural
network
human
brain.
One
use
this
technology
been
to
help
researchers
capture
hidden,
high-dimensional
images
brain
tumors.
These
provide
new
insights
into
nature
improve
treatment
options.
AI
precision
medicine
(PM)
converging
revolutionize
healthcare.
potential
cancer
imaging
interpretation
in
several
ways,
including
more
accurate
tumor
genotyping,
precise
delineation
volume,
better
prediction
clinical
outcomes.
AI-assisted
surgery
an
effective
safe
option
treating
This
review
discusses
various
PM
techniques
used
treatment.
tumors,
i.e.,
genomic
profiling,
microRNA
panels,
quantitative
imaging,
radiomics,
hold
great
promise
future.
However,
there
challenges
must
overcome
these
technologies
reach
their
full